SCHEMBL24933637

SCHEMBL24933637

COc1ccc(COc2ccc(-c3cc(C(N)=O)c(=O)[nH]c3C(F)(F)F)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.44
FFAR1 O14842 3/20 0.44
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
BLM P54132 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
AR P10275 1/20 0.40
PARP10 Q53GL7 1/20 0.40
HDAC3 O15379 1/20 0.39
PARP1 P09874 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933671 0.91 MAOB (0.56) MAOBFFAR1
SCHEMBL24933053 0.90 KDM4E (0.44) ALDH1A1MAPTSMN1; SMN2PARP1PTGDR2
SCHEMBL24933199 0.90 MAOB (0.46) MAOBFFAR1ALDH1A1NPC1RAB9A
SCHEMBL30240807 0.90 MAOB (0.46) MAOBFFAR1ALDH1A1NPC1RAB9A
SCHEMBL24933349 0.90 GSTP1 (0.50) MAOBFFAR1PARP10GSTP1
SCHEMBL24933352 0.89 MAOB (0.42) MAOBFFAR1PARP10HDAC3PARP1
SCHEMBL24932968 0.89 GRM2 (0.40) MAOBFFAR1ALDH1A1MAPTBLM
SCHEMBL30240665 0.89 GRM2 (0.40) MAOBFFAR1ALDH1A1MAPTBLM
SCHEMBL24933351 0.88 MAOB (0.41) MAOBFFAR1PARP10HDAC3PARP1
SCHEMBL24933800 0.88 KCNH2 (0.44) MAOBFFAR1RAB9APARP10HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed